HHS Seeks Industry Input On National Quality Strategy
This article was originally published in The Gray Sheet
Executive SummaryHHS expects device and drug manufacturers, as well as other industry stakeholders, to provide ongoing feedback to aid the agency's development of its official National Quality Strategy for health care, the agency said in a March 21 report to Congress.
You may also be interested in...
Draft recommends research and initiatives that could lead to changes in drug prescribing practices to reduce the likelihood of adverse drug events – and may even include more prescribing if adverse drug events can be mitigated.